We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Partial Surgery Spares Kidney Function

By HospiMedica staff writers
Posted on 10 Mar 2006
A new study finds that a large percentage of patients with small kidney tumors have their entire kidney removed as treatment, even though they may be suitable for surgery that removes only the cancer and spares the rest of the normal kidney, called partial nephrectomy.

Researchers at the University of Michigan Comprehensive Cancer Center (Ann Arbor, USA) looked at data concerning 14,647 people treated from 1988 to 2001 for kidney cancers less than 7 cm in size. More...
During this 13-year interval, only 9.6% of patients were treated with partial nephrectomy, while the remaining 90% had their entire kidney removed. The results of the study appear in the March 2006 issue of the Journal of Urology.

The researchers found that for tumors smaller than 4 cm, removing only the tumor and a small margin of healthy tissue is just as effective at controlling the cancer as removing the entire kidney. However, not everyone with kidney cancer is eligible for partial nephrectomy. While tumor size is a major indicator of eligibility, other factors that should generally be considered include the location of the tumor within the kidney; overall kidney function; the presence of other medical conditions, including diabetes, high blood pressure, and kidney stones; and patient preference.

"For most surgeons, myself included, partial nephrectomy, whether open or laparoscopic, is likely to be a more difficult operation than removing the entire kidney. Many surgeons are able to take the whole kidney out laparoscopically but are less experienced performing partial nephrectomy laparoscopically,” said study author David Miller, M.D., clinical lecturer in urology at the University of Michigan Medical School, offering one explanation for the low prevalence of partial nephrectomy.






Related Links:
University of Michigan Comprehensive Cancer Center

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.